University Of California, San Francisco

University Of California, San Francisco is a research and medical institution operating as a child entity of the State of California Controllers Office; it functions primarily as a federal grant sub-recipient in biomedical research rather than as a prime contractor, and operates under the parent's state-government structure rather than as a commercial vendor.

UCSF's federal footprint reflects a research institution's typical posture: 23 of 26 awards in the source data are prime grants (88%), and 3 are grant sub-awards (12%), with no federal contract prime vehicle seats. The institution's customer concentration is dominated by the National Institutes of Health (grantor agency across multiple awards), with secondary exposure to the Department of Veterans Affairs and the Department of Homeland Security. A separate and unrelated transaction footprint appears in the data — 16 awards tied to the General Services Administration Public Buildings Service Central Office Office of Leasing under Basic Ordering Agreement GS09B02464 — reflecting facility-lease and real-property-management activity that sits outside typical research-institution federal work and likely represents GSA's payment relationship with UCSF for space occupied by federal programs or operations at San Francisco campuses.

Recent sub-award work reflects UCSF's research mission. As a sub-recipient under a Northern California Institute For Research And Education prime grant awarded in August 2026, UCSF provided expertise in sex differences and menopausal cardiometabolic outcomes and coordinated institutional review board and human-subjects training for the Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) combined cohort. Under a University of Pittsburgh prime grant awarded in November 2025, UCSF participated in longitudinal multicenter tau positron-emission-tomography tracer harmonization work. Under a Palo Alto Veterans Institute for Research prime grant awarded in February 2025, UCSF's Zuckerberg San Francisco General Hospital served as a study site for a hepatocellular carcinoma screening outcomes project across safety-net health systems, with faculty leadership and clinical research coordination.

Activity has declined significantly from historical patterns — the source shows twelve awards in 2010, but only two in 2025 and one in 2026 — with combined potential value of $3.4 million across all federal sources and only $808 thousand in cumulative dollars obligated. UCSF does not compete for contracts under set-asides; it operates as a research institution within the state-government parent structure, with federal exposure limited to NIH and other grantor-agency sub-awards and facility-lease relationships managed through the state.